No profile data available.
Theralink Technologies, Inc. (THER) is a healthcare company in the medication development research industry, based in Golden, United States, with about 16 full-time employees.
It reported revenue of $606,796 for fiscal year 2023, up 6.8% from fiscal year 2022, and net income of -$30.95 million. In Q1 2024 (the quarter ended December 31, 2023) revenue was $83,949, up 51.8% from a year before. Its market capitalization was $615,149 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2023; market data as of October 8, 2026.
, a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development.
Theralink Technologies reported $606,796 in revenue for fiscal year 2023, up 6.8% from $567,905 in fiscal year 2022. In Q1 2024 revenue was $83,949.
$615,149 as of October 8, 2026.
Listed companies of a similar size in the same industry (medication development research) include HCW Biologics Inc. (HCWB), Vaccinex, Inc. (VCNX), VivoSim Labs, Inc. (VIVS).